Cizzle Biotechnology (LON:CIZ) Stock Price Up 13.3% – What’s Next?

Cizzle Biotechnology Holdings Plc (LON:CIZ) shares rose 13.3% during trading on Wednesday . The company traded as high as GBX 1.70 and last traded at GBX 1.70. Approximately 1,042,836 shares were traded during trading, an increase of 151% from the average daily volume of 416,243 shares. The stock had previously closed at GBX 1.50.

Cizzle Biotechnology Stock Up 22.5%

The firm has a market capitalization of £7.28 million, a price-to-earnings ratio of -5.74 and a beta of 0.38. The company has a debt-to-equity ratio of -54.35, a current ratio of 0.48 and a quick ratio of 4.66. The business has a fifty day moving average price of GBX 1.51 and a two-hundred day moving average price of GBX 1.55.

About Cizzle Biotechnology

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.